Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform

The OpenSAFELY collaborative, John Tazare, Linda Nab, Bang Zheng, William J Hulme, Amelia C A Green, Helen J Curtis, Viyaasan Mahalingasivam, Rose Higgins, Anna Schultze, Krishnan Bhaskaran, Amir Mehrkar, Andrea Schaffer, Rebecca M Smith, Christopher Bates, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Rosalind M Eggo, Alex J Walker, Michael Marks, Mike Brown, Camille Maringe, Clémence Leyrat, Stephen J W Evans, Ben Goldacre, Brian MacKenna, Jonathan A C Sterne, Laurie A Tomlinson, Ian J Douglas
doi: https://doi.org/10.1101/2023.05.12.23289914

Article Information

doi 
https://doi.org/10.1101/2023.05.12.23289914
History 
  • May 16, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. The OpenSAFELY collaborative,
  2. John Tazare1,*,
  3. Linda Nab2,*,#,
  4. Bang Zheng1,
  5. William J Hulme2,
  6. Amelia C A Green2,
  7. Helen J Curtis2,
  8. Viyaasan Mahalingasivam1,
  9. Rose Higgins2,
  10. Anna Schultze1,
  11. Krishnan Bhaskaran1,
  12. Amir Mehrkar2,
  13. Andrea Schaffer2,
  14. Rebecca M Smith2,
  15. Christopher Bates3,
  16. Jonathan Cockburn3,
  17. John Parry3,
  18. Frank Hester3,
  19. Sam Harper3,
  20. Rosalind M Eggo1,
  21. Alex J Walker2,
  22. Michael Marks1,4,5,
  23. Mike Brown1,4,
  24. Camille Maringe1,
  25. Clémence Leyrat1,
  26. Stephen J W Evans1,
  27. Ben Goldacre2,
  28. Brian MacKenna2,
  29. Jonathan A C Sterne6,7,*,
  30. Laurie A Tomlinson1,* and
  31. Ian J Douglas1,*
  1. 1London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
  2. 2Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, UK
  3. 3TPP, TPP House, 129 Low Lane, Horsforth, Leeds, UK
  4. 4Division of Infection, University College London Hospitals NHS Foundation Trust, London, UK
  5. 5Division of Infection and Immunity, University College London, London, UK
  6. 6Population Health Sciences, University of Bristol, Bristol, UK
  7. 7NIHR Bristol Biomedical Research Centre, Bristol, UK
  1. ↵#Corresponding author; email: linda.nab{at}phc.ox.ac.uk
Back to top
Posted May 16, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform
The OpenSAFELY collaborative, John Tazare, Linda Nab, Bang Zheng, William J Hulme, Amelia C A Green, Helen J Curtis, Viyaasan Mahalingasivam, Rose Higgins, Anna Schultze, Krishnan Bhaskaran, Amir Mehrkar, Andrea Schaffer, Rebecca M Smith, Christopher Bates, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Rosalind M Eggo, Alex J Walker, Michael Marks, Mike Brown, Camille Maringe, Clémence Leyrat, Stephen J W Evans, Ben Goldacre, Brian MacKenna, Jonathan A C Sterne, Laurie A Tomlinson, Ian J Douglas
medRxiv 2023.05.12.23289914; doi: https://doi.org/10.1101/2023.05.12.23289914
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area